He is a physician who practised as a paediatrician for a number of years, before working in the pharmaceutical industry in clinical research and development between 1989 and 2001, when he joined the former MCA (Medicines Control Agency) as Director of the Licensing Division.
Before being appointed as Chief Executive, Dr Hudson was the MHRA’s Licensing Director, responsible for the majority of its medicines licensing activities. He was also the UK delegate to the Committee for Human Medicinal Products (CHMP) and was its vice-chairman from October 2012 to September 2013.
Extra: Ian Hudson
Qualified in medicine from University of London (London Hospital Medical School).
Practiced predominantly in paediatrics after qualifying. Research interest in neonatal haematology.
Various posts at SmithKline Beecham from 1989-2001 within the clinical research and development part of the company.
Joined MCA 2001 as Director of Licensing
CHMP delegate from October 2002 – July 2013 including its Vice Chair from October 2012 – July 2013
CEO from September 2013